A detailed history of Valley National Advisers Inc transactions in Cardiol Therapeutics Inc. stock. As of the latest transaction made, Valley National Advisers Inc holds 5,000 shares of CRDL stock, worth $6,400. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,000
Previous 5,000 -0.0%
Holding current value
$6,400
Previous $10,000 10.0%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

BUY
$1.83 - $4.86 $9,150 - $24,300
5,000 New
5,000 $9,000

Others Institutions Holding CRDL

About Cardiol Therapeutics Inc.


  • Ticker CRDL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 61,942,500
  • Market Cap $79.3M
  • Description
  • Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...
More about CRDL
Track This Portfolio

Track Valley National Advisers Inc Portfolio

Follow Valley National Advisers Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valley National Advisers Inc, based on Form 13F filings with the SEC.

News

Stay updated on Valley National Advisers Inc with notifications on news.